Clinical safety and possible efficacy of tirofiban in combination with intravenous thrombolysis by recombinant tissue plasminogen activator for early treatment of capsular warning syndrome (CWS)

The purpose of this study was to assess the efficacy and safety of the combination of tirofiban with intravenous thrombolysis (IVT) in treating patients with capsular warning syndrome (CWS) who failed to respond to the treatment of intravenous thrombolysis alone. Tirofiban was approved for the treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yunzhu, Li, Shiyong, Hao, Dongdong, Zhang, Zhongping, Yi, Yongxin, Fang, Jiayang, Lin, Weizhi, Zhang, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709144/
https://www.ncbi.nlm.nih.gov/pubmed/36466171
http://dx.doi.org/10.3389/fnins.2022.1026127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709144/
https://www.ncbi.nlm.nih.gov/pubmed/36466171
http://dx.doi.org/10.3389/fnins.2022.1026127

Ejemplares similares